{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3167, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 93, "slideType": "customer_journey", "function": "present_framework", "notes": "The flywheel shows how retailer/OEM investment leads to more inventory, which attracts consumers, leading to more deals and conversion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/93", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-93", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 94, "slideType": "comparison_table", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/94", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-94", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 95, "slideType": "revenue_buildup", "function": "quantify_opportunity", "notes": "The slide uses a simple arithmetic equation structure (Price x Margin = Profit) to illustrate the value proposition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/95", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-95", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 96, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses a tabular structure to explain the decomposition of financial reporting segments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/96", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-96", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 97, "slideType": "key_messages", "function": "present_framework", "notes": "The diagram uses a concentric circle model to show how the three strategic pillars are layered and integrated.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/97", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-97", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 98, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/98", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-98", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 99, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/99", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-99", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7daa-76cd-95e3-88b03c8f4a87", "docSlug": "b06c81d2c693eb3e7474ec90e7aa4553", "documentTitle": "Auto Trader Group | Investor Day Presentation Deck | 100 slides", "authorId": "auto-trader-group", "authorName": "Auto Trader", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 100, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7daa-76cd-95e3-88b03c8f4a87/100", "deckHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87", "deckAnchorHref": "/decks/019de073-7daa-76cd-95e3-88b03c8f4a87#slide-100", "loopMatches": [], "arcBeatMatches": [ { "to": 100, "from": 90, "beatId": "6768a86f-ae5c-40ee-b20b-729cd0ce3ffc", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with a call to action and a summary of key takeaways.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo and ticker symbol.", "imagePath": "https://imgproxy.kitesheet.com/44OBb2-PSgmrf-cwhLgfmX9vf2FaV7topY_EFvJUu1Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85N2UzNGQ2YzRkYjdkOTQ1NDQ0MGZlZTNlZmQ0MzU0NS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/1", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/V6KgADx9ec2hzbLUiuNR7CQollVz1DsyumLPnXXUg4I/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85N2UzNGQ2YzRkYjdkOTQ1NDQ0MGZlZTNlZmQ0MzU0NS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Gu1FFvss8ejXdHrxNmNnCOpa0m52PRMXj2C8rKQOJSA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85N2UzNGQ2YzRkYjdkOTQ1NDQ0MGZlZTNlZmQ0MzU0NS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/nJnquSPWOGaxjRUC0RbrgMlbin6IrtIfVlrCwuVgoe8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85N2UzNGQ2YzRkYjdkOTQ1NDQ0MGZlZTNlZmQ0MzU0NS9wMDAxLnBuZw" }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/2", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/3", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "propose_solution", "function": "present_solution", "notes": "The diagram illustrates a hub-and-spoke model showing systemic interaction of EMMs across various organs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/4", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "bf47ac09-c6e9-4a67-96b8-4dd80291c456", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Propose Solution", "beatSlug": null, "evidence": "Multi-targeted therapeutics to restore homeostasis", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "key_messages", "function": "establish_context", "notes": "The slide uses a calendar to imply a timeline or duration for Long COVID treatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/5", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a three-column structure to frame the problem: Market State, Biological Complexity, and Clinical Need.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/6", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-6", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "54d7f160-8aaf-4a81-bf03-5c5856d59c2a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem Statement", "beatSlug": null, "evidence": "NASH is a complex disease affecting millions, with a need for effective treatment options", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "timeline", "function": "present_framework", "notes": "The slide uses a timeline framework to show trial progression over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/7", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-7", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/8", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-8", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 8, "beatId": "b29034ad-8ac9-466e-9be3-e33b3df8183f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "AXA1125 continues to demonstrate real biological impact and effect in NASH subjects", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a blue box with checkmarks to emphasize the positive attributes of the product.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/9", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-9", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/10", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-10", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "other", "function": "present_framework", "notes": "The slide uses a standard clinical trial flow diagram to illustrate study arms and assessment points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/11", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-11", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 12, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "Standard clinical trial subject disposition flow chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/12", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-12", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes demographic, metabolic, inflammatory, and fibrosis markers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/13", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-13", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/14", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-14", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 15, "slideType": "before_after", "function": "analyze_data", "notes": "The data shows a statistically significant improvement in the high-dose group at Week 24.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/15", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-15", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 15, "from": 15, "beatId": "a87eccd9-9fc2-4303-aa89-5e21f887edea", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Significant improvements in liver stiffness as measured by FibroScan", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 16, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide shows clinical trial data comparing two biomarkers for fibrosis treatment efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/16", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-16", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 17, "slideType": "before_after", "function": "analyze_data", "notes": "Clinical trial data showing statistically significant reductions in ALT for AXA1125 groups compared to placebo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/17", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-17", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Shows statistically significant effects at week 12 for AXA1125 treatment arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/18", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-18", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Data shows proportions of subjects meeting specific thresholds associated with histologic improvements in NASH.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/19", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-19", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/20", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-20", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 21, "slideType": "kpi_overview", "function": "summarize", "notes": "DMC = Data Monitoring Committee; TEAE = Treatment Emergent Adverse Event; SAE = Serious Adverse Event.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/21", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-21", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 22, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/22", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-22", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 23, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/23", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-23", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 24, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a central biological pathway diagram (liver-centric) surrounded by comparative tables showing single-target drugs vs AXA1125's multi-target approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/24", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-24", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 25, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a central biological pathway map (liver/metabolic focus) flanked by comparison tables showing single-target competitors vs AXA1125's multi-target effects.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/25", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-25", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 26, "slideType": "other", "function": "analyze_data", "notes": "The slide uses bar charts to show dose-dependent increases in metabolic markers and a table to show pathway enrichment scores.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/26", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-26", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 27, "slideType": "other", "function": "analyze_data", "notes": "The slide uses a pathway diagram and a bar chart to demonstrate the mechanism of action of AXA1125 in a Primary Human Hepatocyte (PHH) Lipotoxicity Model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/27", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-27", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 28, "slideType": "other", "function": "analyze_data", "notes": "Includes statistical significance markers (*, **, ***) and experimental methodology in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/28", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-28", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 29, "slideType": "other", "function": "analyze_data", "notes": "The slide presents preclinical data from primary human hepatic stellate cells.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/29", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-29", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 30, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/30", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-30", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 24, "name": "Value Chain Walk", "slug": "44-value-chain-walk", "bestFor": "Operations improvement, cost reduction, competitive advantage", "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26", "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways", "position": 1, "objective": "How does AXA1125 address the complex disease pathways of NASH?", "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment", "confidence": 0.6, "description": "Walk through each step of the value chain to identify where value is created or destroyed" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 31, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/31", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-31", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 32, "slideType": "key_messages", "function": "analyze_data", "notes": "Includes a map-based visualization of regional prevalence and a grouped bar chart for age/sex demographics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/32", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-32", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 33, "slideType": "before_after", "function": "analyze_data", "notes": "Uses a before-after-bridge framework to highlight the growth in Fibrosis stage 2-4 prevalence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/33", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-33", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 34, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Data source: Harrison SA et al. J Hepatol. 2021;S0168-8278:00176-8.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/34", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-34", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 35, "slideType": "thesis_headline", "function": "frame_problem", "notes": "The slide uses a background diagram of biological pathways to illustrate complexity, overlaid with a callout box containing the core thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/35", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-35", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 35, "from": 35, "beatId": "4b6e82e4-c142-473e-8444-2a12455e8725", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Complication", "beatSlug": "complication", "evidence": "Targeting a single pathway will not be sufficient to manage most NASH patients", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 36, "slideType": "customer_journey", "function": "frame_situation", "notes": "Uses a gradient bar to illustrate the shift in risk tolerance and clinical priorities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/36", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-36", "loopMatches": [ { "to": 36, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d", "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression", "position": 0, "objective": "What is the risk of not treating NASH effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 37, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a table structure to categorize drug candidates by their biological mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/37", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 38, "slideType": "other", "function": "present_framework", "notes": "The slide outlines a clinical trial protocol for AXA1125.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/38", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 39, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide includes a prominent callout box summarizing the clinical significance of the baseline data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/39", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 40, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/40", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 41, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a simple three-circle layout to categorize the utility of NITs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/41", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 42, "slideType": "other", "function": "establish_context", "notes": "The slide uses a simple Venn-like or hub-and-spoke visual, though the side circles are empty.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/42", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 43, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide compares three groups (Placebo, AXA1125 22.6 BID, AXA1125 33.9 BID) across two time points (Week 12 and Week 24).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/43", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 44, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart compares different trial durations (24 weeks vs 72 weeks vs 18 months) and phases (Ph2b vs Ph3).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/44", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 45, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide title mentions week 12, but the charts explicitly label week 24. This is a common discrepancy in clinical trial decks where data is presented across multiple time points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/45", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 46, "slideType": "key_takeaways", "function": "analyze_data", "notes": "N=931. Data presented for Placebo, OCA 10mg, and OCA 25mg cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/46", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 47, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents longitudinal data from the REGENERATE trial, specifically focusing on FIB-4 scores as a non-invasive test (NIT) for fibrosis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/47", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 48, "slideType": "kpi_overview", "function": "analyze_data", "notes": "P-values are calculated using Cochran-Mantel Haenszel test vs placebo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/48", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 49, "slideType": "before_after", "function": "illustrate_case", "notes": "Figure 5 from a clinical study publication; includes legend for treatment arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/49", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-49", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 50, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a forest plot to visualize odds ratios and confidence intervals for clinical predictors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/50", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-50", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 51, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a dark sidebar for context and a white main area for data presentation. It includes a citation at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/51", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-51", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7e4e-7689-a01c-e0840dac2b61", "docSlug": "97e34d6c4db7d9454440fee3efd43545", "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides", "authorId": "axcella-health", "authorName": "Axcella Therapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 52, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights the efficacy of MGL-3196 in NASH treatment using MRI-PDFF as a biomarker.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/52", "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61", "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-52", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }